nature.com
Leukemia - Abstract of article: Interferon alpha 2 maintenance therapy may enable high rates of treatment discontinuation in chronic myeloid leukemia
http://www.nature.com/leu/journal/vaop/ncurrent/abs/leu201545a.html
Jump to main content. 1331–1335; doi:10.1038/leu.2015.45; published online 20 March 2015. Interferon alpha 2 maintenance therapy may enable high rates of treatment discontinuation in chronic myeloid leukemia. M C Müller. Klinik für Hämatologie /. Onkologie und Immunologie, Universitätsklinikum Gießen und Marburg, Standort Marburg, Philipps Universität Marburg, Marburg, Germany. III Medizinische Klinik, Universitätsmedizin Mannheim, Universität Heidelberg, Mannheim, Germany. 11 patients) and 84 %. Imatini...
nature.com
Leukemia - Abstract of article: Risk stratification for survival and leukemic transformation in essential thrombocythemia: a single institutional study of 605 patients
http://www.nature.com/leu/journal/v21/n2/abs/2404500a.html
Jump to main content. 270–276. doi:10.1038/sj.leu.2404500; published online 14 December 2006. Risk stratification for survival and leukemic transformation in essential thrombocythemia: a single institutional study of 605 patients. Department of Medicine, Division of Hematology, Mayo Clinic, Rochester, MN, USA. Department of Laboratory Medicine, Division of Hematopathology, Mayo Clinic, Rochester, MN, USA. Department of Health Sciences Research, Division of Biostatistics, Mayo Clinic, Rochester, MN, USA.
nature.com
Leukemia
http://www.nature.com/leu
Jump to main content. Covers all aspects of the research and treatment of leukemia and allied diseases. Studies of normal hemopoiesis are covered because of their comparative relevance. Topics of interest are studies on oncogenes, growth factors, stem cells, leukemia genomics, cell cycle, signal transduction, molecular targets for therapy and more. Impact Factor: 12.104*. 1 journal in Hematology. Volume 30, No 8. 2015 Impact Factor 12.104*. Robert Peter Gale, USA. Andreas Hochhaus, Germany. And A tale of...
nature.com
Leukemia - Interleukin-27 inhibits pediatric B-acute lymphoblastic leukemia cell spreading in a preclinical model
http://www.nature.com/leu/journal/v25/n12/full/leu2011158a.html
Jump to main content. 1815–1824; doi:10.1038/leu.2011.158; published online 24 June 2011. Interleukin-27 inhibits pediatric B-acute lymphoblastic leukemia cell spreading in a preclinical model. AIRC Laboratory of Immunology and Tumors, Department of Experimental and Laboratory Medicine, G. Gaslini Institute, Genova, Italy. Department of Pediatrics, Division of Hematology Oncology, University of Padova, Padova, Italy. National Institute for Cancer Research, Animal Model Facility, Genova, Italy. NSG) mice ...
nature.com
Leukemia - The endosteal /`osteoblastic/' niche and its role in hematopoietic stem cell homing and mobilization
http://www.nature.com/leu/journal/v24/n12/full/leu2010214a.html
Jump to main content. 1979–1992; doi:10.1038/leu.2010.214; published online 23 September 2010. The endosteal ‘osteoblastic’ niche and its role in hematopoietic stem cell homing and mobilization. And I G Winkler. Biotherapies Program, Haematopoietic Stem Cell Laboratory, Mater Medical Research Institute, South Brisbane, Queensland, Australia. School of Medicine, University of Queensland, Brisbane, Queensland, Australia. Hematopoietic stem cell; niche; osteoblast; bone marrow; homing; mobilization. And (2)...